Skip to content

Clinical trials

Completed Central Nervous System Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Status: Completed Country / region: Germany Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20102
20114
20121
20143
20161
20171
20192
20204
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Auspex Pharmaceuticals, Inc.2
Novartis Pharmaceuticals2
Alkahest, Inc.1
Avraham Pharmaceuticals Ltd1
Bayer1
CENTOGENE GmbH Rostock1
Eli Lilly and Company1
Guerbet1
Inmune Bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases24
Brain Diseases17
Nervous System Diseases16
Neurodegenerative Diseases10
Movement Disorders9
Parkinson Disease6
Mental Disorders5
Neurologic Manifestations5
Parkinsonian Disorders5
Dementia4

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.